Importantly, the combined use of pioglitazone and IM triggers apoptosis of these leukemic cells suggesting that besides phosphorylation, inhibition of STAT5 expression is of prime importance for resistant CML stem cell eradication. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.